Prescribing SGLT2 Inhibitors in Patients With CKD: Expanding Indications and Practical Considerations
Author(s) -
Kevin Yau,
Atit Dharia,
Ibrahim Alrowiyti,
David Z.I. Cherney
Publication year - 2022
Publication title -
kidney international reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.225
H-Index - 22
ISSN - 2468-0249
DOI - 10.1016/j.ekir.2022.08.016
Subject(s) - dapagliflozin , medicine , diuretic , heart failure , placebo , concomitant , ejection fraction , kidney disease , renal function , intensive care medicine , endocrinology , diabetes mellitus , alternative medicine , type 2 diabetes , pathology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom